Position in BIO
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$19,671
+$16,018 QoQ
Shares Held
67
+346.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#311
of 397 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $3,052,513 across 19 Medical Devices names. BIO ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
12,671 | $1,149,766 | |
| 2 | SYK |
Stryker Corp
|
1,930 | $607,641 | |
| 3 | BSX |
Boston Scientific Corp
|
12,796 | $546,133 | |
| 4 | MDT |
Medtronic plc
|
6,055 | $473,682 | |
| 5 | DXCM |
Dexcom Inc
|
1,146 | $77,183 | |
| 6 | EW |
Edwards Lifesciences Corp
|
581 | $52,557 | |
| 7 | PODD |
Insulet Corp
|
299 | $45,522 | |
| 8 | GMED |
Globus Medical Inc
|
319 | $25,204 |
All Filings in BIO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,671 | 67 | Shares | Sole | 2026-08-06 | |
| 2025-03-31 | $3,653 | 15 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $7,884 | 24 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $6,022 | 18 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $4,369 | 16 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $5,533 | 16 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||